{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:19:01Z","timestamp":1790169541459,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Society of Cytopathology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jasc.2022.06.003","type":"journal-article","created":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T12:08:38Z","timestamp":1655813318000},"page":"241-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Cytology and LGBT+ health: establishing inclusive cancer screening programs"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0568-2309","authenticated-orcid":false,"given":"Margaret L.","family":"Compton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayne S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy G.","family":"Weeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0874-3207","authenticated-orcid":false,"given":"Vivian L.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim A.","family":"Ely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jasc.2022.06.003_bib1","first-page":"755","article-title":"International incidence rates of invasive cervical cancer after introduction of cytological screening","volume":"8","author":"Gustafsson","year":"1997","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jasc.2022.06.003_bib2","first-page":"384","article-title":"Cancer and lesbian, gay, bisexual, transgender\/transsexual, and queer\/questioning (LGBTQ) populations","volume":"65","author":"Quinn","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2022.06.003_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1188\/20.ONF.44-55","article-title":"Barriers and facilitators to cancer screening among LGBTQ individuals with cancer","volume":"47","author":"Haviland","year":"2020","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.jasc.2022.06.003_bib4","series-title":"The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding","year":"2011"},{"key":"10.1016\/j.jasc.2022.06.003_bib11","author":"Flores"},{"key":"10.1016\/j.jasc.2022.06.003_bib12","author":"Wilson"},{"key":"10.1016\/j.jasc.2022.06.003_bib13","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1520-6300(200003\/04)12:2<151::AID-AJHB1>3.0.CO;2-F","article-title":"How sexually dimorphic are we? Review and synthesis","volume":"12","author":"Blackless","year":"2000","journal-title":"Am J Hum Biol"},{"key":"10.1016\/j.jasc.2022.06.003_bib14","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jasc.2022.06.003_bib15","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/modpathol.2015.54","article-title":"Microanatomy of the cervical and anorectal squamocolumnar junctions: a proposed model for anatomical differences in HPV-related cancer risk","volume":"28","author":"Yang","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jasc.2022.06.003_bib16","author":"Fernandez"},{"issue":"3 Suppl 1","key":"10.1016\/j.jasc.2022.06.003_bib17","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/LGT.0000000000000117","article-title":"Screening for anal cancer in women","volume":"19","author":"Moscicki","year":"2015","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.jasc.2022.06.003_bib18","series-title":"Screening for Anal Dysplasia and Cancer in Adults With HIV","author":"Hirsch","year":"2022"},{"key":"10.1016\/j.jasc.2022.06.003_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/DCR.0000000000001114","article-title":"Prepared on behalf of the clinical practice guidelines committee of the American society of colon and rectal surgeons. The American society of colon and rectal surgeons clinical practice guidelines for anal squamous cell cancers (revised 2018)","volume":"61","author":"Stewart","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jasc.2022.06.003_bib20","series-title":"Howard Brown Health Anal Dysplasia Screening Guidelines","author":"Bucher","year":"2019"},{"key":"10.1016\/j.jasc.2022.06.003_bib21","doi-asserted-by":"crossref","first-page":"507","DOI":"10.7326\/M14-2768","article-title":"North American acquired immunodeficiency syndrome (AIDS) cohort collaboration on research and design of the international epidemiologic databases to evaluate AIDS. Cumulative incidence of cancer among persons with HIV in North America: a cohort study","volume":"163","author":"Silverberg","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jasc.2022.06.003_bib22","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/jnci\/djs371","article-title":"Impact of the HIV epidemic on the incidence rates of anal cancer in the United States","volume":"104","author":"Shiels","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jasc.2022.06.003_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5858\/arpa.2017-0242-RA","article-title":"Anal cytology: institutional statistics, correlation with histology, and development of multidisciplinary screening program with review of the current literature","volume":"143","author":"Morency","year":"2019","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2022.06.003_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/dc.23858","article-title":"Unsatisfactory exfoliative anal cytology samples, 15-year experience with histologic, cytologic, and molecular follow-up","volume":"46","author":"Khattab","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.jasc.2022.06.003_bib25","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.5858\/arpa.2012-0574-CP","article-title":"Room for improvement: initial experience with anal cytology: observations from the College of American Pathologists interlaboratory comparison program in nongynecologic cytology","volume":"137","author":"Darragh","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.jasc.2022.06.003_bib26","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jasc.2020.07.132","article-title":"The interpretation of high-grade squamous intraepithelial lesion on anal cytology: a comparative analysis with the cervical Papanicolaou test","volume":"9","author":"Patel","year":"2020","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2022.06.003_bib27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/QAD.0000000000002795","article-title":"High-risk human papillomavirus test in anal smears: can it optimize the screening for anal cancer?","volume":"35","author":"Kimura","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.jasc.2022.06.003_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jasc.2021.03.007","article-title":"Evaluation of high-risk human papillomavirus testing and anal cytology to detect high-grade anal intraepithelial neoplasia","volume":"10","author":"Swanson","year":"2021","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2022.06.003_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/514194","article-title":"Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men","volume":"177","author":"Palefsky","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jasc.2022.06.003_bib30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/cid\/ciz831","article-title":"Routine screening of anal cytology in persons with human immunodeficiency virus and the impact on invasive anal cancer: a prospective cohort study","volume":"71","author":"Revollo","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jasc.2022.06.003_bib31","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/cid\/ciz836","article-title":"Screening for anal cancer in the population living with human immunodeficiency virus: a step closer?","volume":"71","author":"Bonnez","year":"2020","journal-title":"Clin Infectilous Dis"},{"key":"10.1016\/j.jasc.2022.06.003_bib32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/AOG.0000000000004684","article-title":"ACOG committee opinion no. 823, health care for transgender and gender diverse individuals: correction","volume":"139","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jasc.2022.06.003_bib33","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jasc.2022.06.003_bib34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/jwh.2009.1393","article-title":"Barriers to cervical cancer screening among lesbians","volume":"19","author":"Tracy","year":"2010","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jasc.2022.06.003_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/1557988320925691","article-title":"Bridging barriers to cervical cancer screening in transgender men: a scoping review","volume":"14","author":"Dhillon","year":"2020","journal-title":"Am J Mens Health"},{"key":"10.1016\/j.jasc.2022.06.003_bib36","series-title":"The Report of the 2015 U.S. Transgender Survey","author":"James","year":"2016"},{"key":"10.1016\/j.jasc.2022.06.003_bib37","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/13691058.2016.1177203","article-title":"Perceptions of cervical cancer risk and screening among transmasculine individuals: patient and provider perspectives","volume":"18","author":"Ag\u00e9nor","year":"2016","journal-title":"Cult Health Sex"},{"key":"10.1016\/j.jasc.2022.06.003_bib38","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1089\/jwh.2018.7384","article-title":"Gynecologic health care providers' willingness to provide routine care and Papanicolaou tests for transmasculine individuals","volume":"28","author":"Shires","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.jasc.2022.06.003_bib39","doi-asserted-by":"crossref","first-page":"106071","DOI":"10.1016\/j.ypmed.2020.106071","article-title":"Barriers and facilitators to cervical cancer screening among transgender men and non-binary people with a cervix: a systematic narrative review","volume":"135","author":"Connolly","year":"2020","journal-title":"Prev Med"},{"key":"10.1016\/j.jasc.2022.06.003_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/cyt.12525","article-title":"Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: challenges in detecting dysplasia","volume":"29","author":"Adkins","year":"2018","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2022.06.003_bib41","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cncy.22259","article-title":"Cytomorphologic findings of cervical Pap smears from female-to-male transgender patients on testosterone therapy","volume":"128","author":"Williams","year":"2020","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.jasc.2022.06.003_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jasc.2021.01.004","article-title":"Cervical Papanicolaou tests in the female-to-male transgender population: should the adequacy criteria be revised in this population? An institutional experience","volume":"10","author":"Plummer","year":"2021","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2022.06.003_bib43","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s11606-013-2753-1","article-title":"Female-to-male patients have high prevalence of unsatisfactory Paps compared to non-transgender females: implications for cervical cancer screening","volume":"29","author":"Peitzmeier","year":"2014","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jasc.2022.06.003_bib44","doi-asserted-by":"crossref","first-page":"e0190172","DOI":"10.1371\/journal.pone.0190172","article-title":"Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients","volume":"13","author":"Reisner","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jasc.2022.06.003_bib45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jasc.2019.05.003","article-title":"Self-collected Papanicolaou tests in the United States market: more questions than answers","volume":"8","author":"Staats","year":"2019","journal-title":"J Am Soc Cytopathol"},{"key":"10.1016\/j.jasc.2022.06.003_bib46","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s13023-020-01491-9","article-title":"Mayer-Rokitansky-K\u00fcster-Hauser (MRKH) syndrome: a comprehensive update","volume":"15","author":"Herlin","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jasc.2022.06.003_bib47","series-title":"StatPearls","article-title":"Androgen Insensitivity Syndrome. 2021","author":"Singh","year":"2022"},{"key":"10.1016\/j.jasc.2022.06.003_bib48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s00467-014-2875-7","article-title":"The long-term management and outcomes of cloacal anomalies","volume":"30","author":"Fernando","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.jasc.2022.06.003_bib49","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0002-9378(29)90460-9","article-title":"Primary carcinoma of the vagina following a Baldwin reconstruction of the vagina","volume":"18","author":"Ritchie","year":"1929","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jasc.2022.06.003_bib50","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000504936","article-title":"HPV-related neovaginal squamous cell carcinoma presenting as lung metastasis after male-to-female gender confirmation surgery","volume":"13","author":"Wang","year":"2020","journal-title":"Case Rep Oncol"},{"key":"10.1016\/j.jasc.2022.06.003_bib51","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpurol.2006.07.010","article-title":"Cancer of the neovagina","volume":"3","author":"Schober","year":"2007","journal-title":"J Pediatr Urol"},{"key":"10.1016\/j.jasc.2022.06.003_bib52","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.fertnstert.2011.07.1099","article-title":"Impact of human papillomavirus infection on the neovaginal and vulval tissues of women who underwent surgical treatment for Mayer-Rokitansky-Kuster-Hauser syndrome","volume":"96","author":"Frega","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jasc.2022.06.003_bib53","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/1471-0528.15404","article-title":"Vaginal prevalence of human papillomavirus infections in women with uterovaginal aplasia before and after laparoscopically assisted creation of a neovagina: a prospective epidemiological observational study","volume":"126","author":"Rall","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.jasc.2022.06.003_bib54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejogrb.2021.03.030","article-title":"Screening for HPV and dysplasia in transgender patients: do we need it?","volume":"260","author":"Mohr","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jasc.2022.06.003_bib55","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1136\/sextrans-2015-052456","article-title":"Symptomatic HPV-related neovaginal lesions in transgender women: case series and review of literature","volume":"92","author":"van der Sluis","year":"2016","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.jasc.2022.06.003_bib56","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2303.2009.00663.x","article-title":"Cytology of the 'penile' neovagina in transsexual women","volume":"21","author":"Weyers","year":"2010","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2022.06.003_bib57","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/cyt.12417","article-title":"Cytology of the neovagina in transgender women and individuals with congenital or acquired absence of a natural vagina","volume":"28","author":"Grosse","year":"2017","journal-title":"Cytopathology"},{"key":"10.1016\/j.jasc.2022.06.003_bib58","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1210\/clinem\/dgaa546","article-title":"Approach to interpreting common laboratory pathology tests in transgender individuals","volume":"106","author":"Cheung","year":"2021","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of the American Society of Cytopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294522000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213294522000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:47:17Z","timestamp":1761979637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213294522000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2213294522000606"],"URL":"https:\/\/doi.org\/10.1016\/j.jasc.2022.06.003","relation":{},"ISSN":["2213-2945"],"issn-type":[{"value":"2213-2945","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytology and LGBT+ health: establishing inclusive cancer screening programs","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Society of Cytopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jasc.2022.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society of Cytopathology.","name":"copyright","label":"Copyright"}]}}